GreenHouse Holdings, Inc. (OTCQB:GRHU), recently announced that the Company is completing the necessary steps to Up-List its shares to a senior U.S. stock exchange. In order to facilitate the transition, GreenHouse established an independent board and appointed PKF, a nationally recognized accounting firm, as their SEC auditors.
“Graduating to a senior U.S. exchange is a high priority for the company given the progress we have made in securing multiple contracts with the U.S. Military and Fortune 100 industrial customers,” said John Galt, GreenHouse Founder & Executive Chairman. “We believe transitioning to a larger exchange is the next logical step in the Company’s future growth and will allow us to gain exposure and be recognized by a broader segment of the investment community. We have witnessed that a number of companies which Up-List to national exchanges experienced impressive increases in liquidity. GreenHouse is confident that now is the appropriate time to move to a senior exchange, as our operations have increased both domestically and abroad. The Up-Listing will allow us to attract additional investors as we strive to improve shareholder value.”
GreenHouse, through its subsidiary, R Squared Contracting, Inc., provides energy efficiency products and technologies to the residential, commercial, and industrial building markets. GreenHouse also offers ethanol fuel and ethanol production technologies to residential, corporate, and government customers. In addition, GreenHouse distributes E-Fuel MicroFueler, as well as ethanol production systems to produce ethanol using sugar, algae or waste from distilleries and breweries. Further, GreenHouse operates an aquaponic, vegetable, and fish farm for residential customers, and the food and restaurant industry. GreenHouse supplies its products through outsourced manufacturers and assembly from third-party subcontractors. GreenHouse was founded in 2007 and is headquartered in San Diego, California.
Associated Banc-Corp (Nasdaq:ASBC) announced the plan to open a larger Oconomowoc, Wisconsin location. Positioned near the Pabst Farms shopping district, the new Associated branch will replace the site currently located in the Whitman Park Shopping Center on E. Summit Avenue in Oconomowoc as well as the branch located on Main Street in Dousman. Associated Bank employees at both branches will transition to the new location near Pabst Farms. Customers in both communities have been notified of the change of locations.
Associated Banc-Corp is a diversified bank holding company with total assets of $23 billion. Headquartered in Green Bay, Wis., Associated has 290 banking offices serving approximately 160 communities in Wisconsin, Minnesota, and Illinois. Associated offers a full range of traditional banking services and a variety of other financial products and services.
OmniVision Technologies Inc. (Nasdaq:OVTI), a leading developer of advanced digital imaging solutions, introduced the OV8820, a 1/3.2-inch 8-megapixel RAW CMOS image sensor based on OmniVision’s proven 1.4-micron OmniBSI™ pixel architecture. The sensor delivers high frame rate 1080p/30 and 720p/60 high-definition (NYSE:HD) video with electronic image stabilization (NYSEARCA:EIS) and full horizontal field of view (FOV) designed specifically to meet the demands of the rapidly growing smart phone markets. The feature rich OV8820 also offers advanced video capabilities that support mobile YouTube and Facebook applications, making it an ideal solution for tomorrow’s video-centric camera phones.
OmniVision Technologies is a leading developer of advanced digital imaging solutions. Its award-winning CMOS imaging technology enables superior image quality in many of today’s consumer and commercial applications, including mobile phones, notebooks and webcams, digital still and video cameras, security and surveillance, entertainment devices, automotive and medical imaging systems.
BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) announced that six holders of its 2.50% Convertible Senior Subordinated Notes due 2013 have agreed to exchange $87.0 million in aggregate principal amount of the notes for approximately 5.25 million shares of the Company’s common stock. The notes represented approximately 50% of the previously outstanding principal amount.
BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company’s product portfolio comprises four approved products and multiple clinical and pre-clinical product candidates.
Approved products include Naglazyme® (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; Kuvan® (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany; and Firdapse™ (amifampridine phosphate), which has been approved by the European Commission for the treatment of Lambert Eaton Myasthenic Syndrome (LEMS).
Signup for FREE Daily Stock Alerts From CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE) has received ten thousand dollars in cash and anticipates another ten thousand dollars in cash from the company for 60 days of advertisement services for Green House Holdings, Inc. (OTCQB:GRHU). In addition to the cash, Crown Equity Holdings Inc. (OTCPK:CRWE) also anticipates receiving 20,000 shares of 144 restricted stocks from a third party.